Mahamaya Lifesc.

  • Market Cap: Micro Cap
  • Industry: Pesticides & Agrochemicals
  • ISIN: INE0U9D01019
  • NSEID:
  • BSEID: 544611
INR
147.00
14 (10.53%)
BSENSE

Dec 05

BSE+NSE Vol: 121200

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.21 lacs (33.25%) Volume

Shareholding (Nov 2025)

FII

6.39%

Held by 4 FIIs

DII

3.72%

Held by 1 DIIs

Promoter

56.35%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pesticides & Agrochemicals

stock-summary
Market cap

INR 317 Cr (Micro Cap)

stock-summary
P/E

24.00

stock-summary
Industry P/E

31

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.09

stock-summary
Return on Equity

25.71%

stock-summary
Price to Book

6.20

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Board Meeting Outcome for Submission Of Half Year Results - September 2025

02-Dec-2025 | Source : BSE

Submission of Half Year results - September 2025

Submission Of Half Yearly Financial Results - September 2025

02-Dec-2025 | Source : BSE

Submission of Half Yearly Financial Results - September 2025

Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results

26-Nov-2025 | Source : BSE

Mahamaya Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/12/2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the half year ended 30.09.2025

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
2.80
Debt to EBITDA (avg)
3.33
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
2.25
Tax Ratio
25.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.06%
ROCE (avg)
17.93%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
24
Industry P/E
31
Price to Book Value
6.20
EV to EBIT
16.04
EV to EBITDA
14.87
EV to Capital Employed
3.50
EV to Sales
1.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
21.80%
ROE (Latest)
25.71%
Technicals key factors
Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Nov 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 4 FIIs (6.39%)

Promoter with highest holding

Krishnamurthy Ganesan (21.86%)

Highest Public shareholder

Pink Tiger Alliances Llp (10.35%)

Individual Investors Holdings

12.72%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Mahamaya Lifesc."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "163.06",
          "val2": "146.23",
          "chgp": "11.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.58",
          "val2": "13.33",
          "chgp": "16.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.85",
          "val2": "3.55",
          "chgp": "8.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.53",
          "val2": "7.25",
          "chgp": "17.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.55%",
          "val2": "9.12%",
          "chgp": "0.43%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Mahamaya Lifesc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 63.49% vs 17.87% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 147.89% vs 39.20% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "264.15",
          "val2": "161.57",
          "chgp": "63.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.94",
          "val2": "13.24",
          "chgp": "73.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.83",
          "val2": "5.90",
          "chgp": "15.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "12.94",
          "val2": "5.22",
          "chgp": "147.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.68%",
          "val2": "8.19%",
          "chgp": "0.49%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
163.06
146.23
11.51%
Operating Profit (PBDIT) excl Other Income
15.58
13.33
16.88%
Interest
3.85
3.55
8.45%
Exceptional Items
0.00
0.00
Standalone Net Profit
8.53
7.25
17.66%
Operating Profit Margin (Excl OI)
9.55%
9.12%
0.43%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Consolidated) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
264.15
161.57
63.49%
Operating Profit (PBDIT) excl Other Income
22.94
13.24
73.26%
Interest
6.83
5.90
15.76%
Exceptional Items
0.00
0.00
Consolidate Net Profit
12.94
5.22
147.89%
Operating Profit Margin (Excl OI)
8.68%
8.19%
0.49%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 63.49% vs 17.87% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 147.89% vs 39.20% in Mar 2024

stock-summaryCompany CV
About Mahamaya Lifesciences Ltd stock-summary
stock-summary
Mahamaya Lifesciences Ltd
Micro Cap
Pesticides & Agrochemicals
Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as "Mahamaya Life Sciences Private Limited" by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002. Further, Company's name was changed from "Mahamaya Life Sciences Private Limited" to "Mahamaya Lifesciences Private Limited" dated February 15, 2016. The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre.
Company Coordinates stock-summary
Icon
No Company Details Available